GGrantIndex
← Leaderboards

Lawrence D'angelo

Children'S Research Institute

$13,627,486
Attributed
$13,627,486
Total exposure
35
Grants
29
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.6M · FY200515
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15

Funding mix

By agency

NIH$13,132,636 · 34
CDC$494,850 · 1

By mechanism

U01$10,083,297 · 2
U10$2,781,837 · 1
U65$494,850 · 1
M01$267,502 · 31

Top collaborators

No co-investigators on record.

Most similar at Children'S Research Institute

Same institution · by research overlap

Others in their field

Top investigators on “Research Personnel

Research focus

Research PersonnelInstitutionUnited States National Institutes Of HealthAdolescentSourceGrantComputer Retrieval Of Information On Scientific Projects DatabaseResourcesFundingBaseHiv InfectionsSafetyYouthAnti-Retroviral AgentsClinical ResearchCaringRandomizedAdolescent Medicine Trials NetworkPsychologicYoung AdultAids/Hiv ProblemVaccinationLifeDesign

Grant awards (53)

Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN)$524,879
U01 · FY2015 · HD · contact PI
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN)$655,934
U01 · FY2014 · HD · contact PI
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN)$321,584
U01 · FY2013 · HD · contact PI
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN)$641,964
U01 · FY2012 · HD · contact PI
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN)$635,783
U01 · FY2011 · HD · contact PI
HUMAN IMMUNODEFICIENCY VIRUS(HIV) PREVENTION PROJECTS FOR COMMUNITY BASED ORGS$254,800
U65 · FY2011 · PS · contact PI
Adolescent Medicine Trials Network for HIV/AIDS Interve*$796,597
U01 · FY2010 · HD · contact PI
HUMAN IMMUNODEFICIENCY VIRUS(HIV) PREVENTION PROJECTS FOR COMMUNITY BASED ORGS$240,050
U65 · FY2010 · PS · contact PI
ATN 063: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF THE SAFETY A$17,718
M01 · FY2010 · RR · contact PI
ATN 070: PSYCHOSOCIAL NEEDS OF HIV+ YOUNG MEN WHO HAVE SEX WITH MEN (YMSM), V$6,253
M01 · FY2010 · RR · contact PI
ATN 064: IMMUNOGENICITY, SAFETY, TOLERABILITY, AND BEHAVIORAL CONSEQUENCES OF$6,253
M01 · FY2010 · RR · contact PI
ATN 061: PRESERVATION AND EXPANSION OF T-CELL SUBSETS FOLLOWING HAART DE-INTE$2,084
M01 · FY2010 · RR · contact PI
Adolescent Medicine Trials Network for HIV/AIDS Interve*$783,300
U01 · FY2009 · HD · contact PI
ATN 063: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF THE SAFETY A$11,130
M01 · FY2009 · RR · contact PI
ATN 024: A RANDOMIZED, OPEN-LABEL TRIAL OF THREE HEPATITIS B VACCINATION$5,569
M01 · FY2009 · RR · contact PI
ATN 061: PRESERVATION AND EXPANSION OF T-CELL SUBSETS FOLLOWING HAART DE-INTE$2,789
M01 · FY2009 · RR · contact PI
ATN 048: CORRELATES OF HBV-SPECIFIC B CELL MEMORY FOLLOWING VACCINATION IN HIV$2,781
M01 · FY2009 · RR · contact PI
Adolescent Medicine Trials Network for HIV/AIDS Interve*$762,583
U01 · FY2008 · HD · contact PI
Improving Minority Child Health in Washington, D.C$691,922
U10 · FY2008 · HD · contact PI
ATN 025: HEPATITIS B VACCINATION IN YOUTHS$32,283
M01 · FY2008 · RR · contact PI
ATN 015: SHORT-CYCLE THERAPY IN ADOLESCENTS WITH ESTABLISHED VIRAL SUPPRESSION$32,283
M01 · FY2008 · RR · contact PI
ATN 024: A RANDOMIZED, OPEN-LABEL TRIAL OF THREE HEPATITIS B VACCINATION$28,240
M01 · FY2008 · RR · contact PI
ATN 021B: PREVALENCE OF MORPHOLOGIC AND METABOLIC ABNORMALITIES IN HIV INFECTED$16,136
M01 · FY2008 · RR · contact PI
PREVALENCE OF MORPHOLOGIC AND METABOLIC ABNORMALITIES IN HIV INFECTED AND UNINFE$8,074
M01 · FY2008 · RR · contact PI
ATN 048: CORRELATES OF HBV-SPECIFIC B CELL MEMORY FOLLOWING VACCINATION IN HIV$4,031
M01 · FY2008 · RR · contact PI
Improving Minority Child Health in Washington, D.C$690,170
U10 · FY2007 · HD · contact PI
Adolescent Medicine Trials Network for HIV/AIDS Interve*$545,112
U01 · FY2007 · HD · contact PI
ATN 025: HEPATITIS B VACCINATION IN YOUTHS$8,117
M01 · FY2007 · RR · contact PI
ATN 015: SHORT-CYCLE THERAPY IN ADOLESCENTS WITH ESTABLISHED VIRAL SUPPRESSION$8,117
M01 · FY2007 · RR · contact PI
ATN 024: A RANDOMIZED, OPEN-LABEL TRIAL OF THREE HEPATITIS B VACCINATION$7,100
M01 · FY2007 · RR · contact PI
ATN 021B: PREVALENCE OF MORPHOLOGIC AND METABOLIC ABNORMALITIES IN HIV INFECTED$4,057
M01 · FY2007 · RR · contact PI
PREVALENCE OF MORPHOLOGIC AND METABOLIC ABNORMALITIES IN HIV INFECTED AND UNINFE$2,030
M01 · FY2007 · RR · contact PI
ATN 048: CORRELATES OF HBV-SPECIFIC B CELL MEMORY FOLLOWING VACCINATION IN HIV$1,013
M01 · FY2007 · RR · contact PI
Improving Minority Child Health in Washington, D.C$697,154
U10 · FY2006 · HD · contact PI
Adolescent Medicine Trials Network for HIV/AIDS Interve*$492,755
U01 · FY2006 · HD · contact PI
ATN 024: A RANDOMIZED, OPEN-LABEL TRIAL OF THREE HEPATITIS B VACCINATION$16,220
M01 · FY2006 · RR · contact PI
ATN 025: HEPATITIS B VACCINATION IN YOUTHS$8,110
M01 · FY2006 · RR · contact PI
ATN 022: A NOVEL METHOD TO DETERMINE HIV INCIDENCE AMONG YOUTH AND ATN 029 SUB-S$5,405
M01 · FY2006 · RR · contact PI
PREVALENCE OF MORPHOLOGIC AND METABOLIC ABNORMALITIES IN HIV INFECTED AND UNINFE$5,405
M01 · FY2006 · RR · contact PI
ATN 026, EVALUATION OF HIV-SPECIFIC CD8+ T-CELL RESPONSES AND ESCAPE MUTATIONS$4,055
M01 · FY2006 · RR · contact PI
ATN 015: SHORT-CYCLE THERAPY IN ADOLESCENTS WITH ESTABLISHED VIRAL SUPPRESSION$2,582
M01 · FY2006 · RR · contact PI
Improving Minority Child Health in Washington, D.C$702,591
U10 · FY2005 · HD
ADOLESCENT MEDICINE TRIALS NETWORK FOR HIV/AIDS$591,626
U01 · FY2005 · HD
ATN 015: AIDS: SHORT-CYCLE THERAPY IN ADOLESCENTS W/ ESTABLISH VIRAL SUPPRESSION$7,279
M01 · FY2005 · RR
ATN-026: HIV-SPECIFIC CD8+ T-CELL RESPONSE &ESCAPEMUTATION &DIS PROGRESSION$3,236
M01 · FY2005 · RR
ATN 021 ABNORMALITIES IN HIV INFECTED &UNIFECTED YOUNG WOMEN$3,233
M01 · FY2005 · RR
ATN 022: DETERMINE HIV INCIDENCE;ATN 029: HIV-1 RESISTANCE MARKERS IN YOUTH$1,616
M01 · FY2005 · RR
ADOLESCENT MEDICINE TRIALS NETWORK FOR HIV/AIDS$755,526
U01 · FY2004 · HD
ATN 026, EVALUATION OF HIV-SPECIFIC CD8+ T-CELL RESPONSES AND ESCAPE MUTATIONS$4,303
M01 · FY2004 · RR
ADOLESCENT MEDICINE TRIALS NETWORK FOR HIV/AIDS$626,369
U01 · FY2003 · HD
ADOLESCENT MEDICINE TRIALS NETWORK FOR HIV/AIDS$453,397
U01 · FY2002 · HD
ADOLESCENT MEDICINE TRIAL NETWORK FOR HIV/AIDS$948,056
U01 · FY2001 · HD
ADOLESCENT MEDICINE HIV/AIDS RESEARCH NETWORK$547,832
U01 · FY2000 · HD